XTANT MEDICAL HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.72 USD | -3.38% |
|
-4.14% | -36.28% |
| 15/05 | Earnings Flash (XTNT) XTANT MEDICAL HOLDINGS Reports Q1 Revenue $27.9M, vs. Street Est of $25.8M | MT |
| 15/05 | Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the Xtant Medical Holdin...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
Calendar
01/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.72
USD
Average target price
2.35
USD
Spread / Average Target
+226.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.28% | 9.38Cr | |
| +13.73% | 13TCr | |
| -8.17% | 1.1TCr | |
| -4.33% | 835.41Cr | |
| +41.80% | 567.43Cr | |
| -21.94% | 471.78Cr | |
| +7.81% | 342.28Cr | |
| -10.26% | 275.74Cr | |
| -10.29% | 210.67Cr | |
| -13.58% | 192.14Cr |
- Stock Market
- Equities
- XTNT Stock
- News Xtant Medical Holdings, Inc.
- Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024
